Heart Test Laboratories Inc
NASDAQ:HSCS

Watchlist Manager
Heart Test Laboratories Inc Logo
Heart Test Laboratories Inc
NASDAQ:HSCS
Watchlist
Price: 2.66 USD -8.59% Market Closed
Market Cap: 7m USD

Heart Test Laboratories Inc
Income from Continuing Operations

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Heart Test Laboratories Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Heart Test Laboratories Inc
NASDAQ:HSCS
Income from Continuing Operations
-$8.8m
CAGR 3-Years
-22%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$2.8B
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$2.9B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$14B
CAGR 3-Years
21%
CAGR 5-Years
33%
CAGR 10-Years
19%
IDEXX Laboratories Inc
NASDAQ:IDXX
Income from Continuing Operations
$1B
CAGR 3-Years
15%
CAGR 5-Years
16%
CAGR 10-Years
19%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.8B
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
18%
No Stocks Found

Heart Test Laboratories Inc
Glance View

Market Cap
7m USD
Industry
Health Care

Heart Test Laboratories Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Southlake, Texas and currently employs 12 full-time employees. The company went IPO on 2022-06-15. Heart Test Laboratories, Inc. is a medical technology company focused on developing artificial intelligence (AI) based technology to an electrocardiogram (ECG) to expand and improve an ECG’s clinical usefulness. The Company’s product candidate, the MyoVista wavECG, or the MyoVista, is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista is a 12-lead resting ECG device that features its algorithm developed to detect cardiac dysfunction in the diastolic phase, specifically slower than normal left ventricular relaxation rates. The MyoVista uses electrical information from the heart captured during a standard resting 12-lead ECG test as inputs to an artificial intelligence-based algorithm. The MyoVista detects whether a patient is negative or positive for abnormally slow left ventricular diastolic relaxation rates.

HSCS Intrinsic Value
0.04 USD
Overvaluation 99%
Intrinsic Value
Price

See Also

What is Heart Test Laboratories Inc's Income from Continuing Operations?
Income from Continuing Operations
-8.8m USD

Based on the financial report for Apr 30, 2025, Heart Test Laboratories Inc's Income from Continuing Operations amounts to -8.8m USD.

What is Heart Test Laboratories Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-18%

Over the last year, the Income from Continuing Operations growth was -33%. The average annual Income from Continuing Operations growth rates for Heart Test Laboratories Inc have been -22% over the past three years , -18% over the past five years .

Back to Top